Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2004 R43 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete
2007 R33 RFA-CA-07-016 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS Complete
2010 R21 RFA-CA-09-008 MITRA, ROBI D WASHINGTON UNIVERSITY HIGHLY PARALLEL EDMAN SEQUENCING OF INDIVIDUAL PEPTIDE MOLECULES Complete
2014 R33 RFA-CA-13-002 LOEB, LAWRENCE A UNIVERSITY OF WASHINGTON VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING Complete
2017 R33 RFA-CA-16-002 SINGH, ANKUR CORNELL UNIVERSITY LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics Complete
2001 R33 PAR-98-067 SHACKNEY, STANLEY E ALLEGHENY-SINGER RESEARCH INSTITUTE MOLECULAR PROFILING OF CELLS BY LASER SCANNING CYTOMETRY Complete
2003 R33 PAR-01-106 RONINSON, IGOR B ORDWAY RESEARCH INSTITUTE, INC. FUNCTION-BASED SELECTION OF TARGET GENES IN TUMOR CELLS Complete
2003 R41 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2007 R21 RFA-CA-07-002 XU, XIAOWEI UNIVERSITY OF PENNSYLVANIA ULTRASENSITIVE FACTT ASSAYS FOR SERUM BIOMARKERS Complete
2009 R43 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete
2013 R33 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2016 R33 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2020 R33 RFA-CA-19-020 HIGGINSON, DANIEL SLOAN-KETTERING INST CAN RESEARCH Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways Complete
2000 R43 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
2006 R21 RFA-CA-06-003 HAAB, BRIAN B. VAN ANDEL RESEARCH INSTITUTE DEFINING SECRETED GLYCAN ALTERATIONS IN PANCREATIC CANCER Complete
2009 R21 RFA-CA-08-006 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY DEVELOPING A SINGLE CELL GROWTH MONITOR FOR CLASSIFYING THERAPEUTIC RESPONSE Complete
2012 R33 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2016 R21 RFA-CA-15-002 HELD, JASON M. WASHINGTON UNIVERSITY DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER Complete
2019 R33 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Complete
2000 R21 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2002 R21 PAR-99-102 MEHTA, ANAND S THOMAS JEFFERSON UNIVERSITY IDENTIFICATION OF SERUM GLYCOSYLATION MARKERS OF HCC Complete
2005 R21 RFA-CA-05-004 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED CELL PREPARATION IN TUBES FOR 3D MICROSCOPY Complete
2008 R21 RFA-CA-07-035 EDWARDS, JEREMY S. UNIVERSITY OF NEW MEXICO SEQUENCING CHR. 6 IN MELANOMA PATIENTS Complete
2011 R21 RFA-CA-10-005 LAVIE, ARNON UNIVERSITY OF ILLINOIS AT CHICAGO ENZYME-DELIVERY SCAFFOLD TECHNOLOGY FOR TARGETED CANCER KILLING. Complete
2015 R21 RFA-CA-14-005 GERTZ, JASON UNIVERSITY OF UTAH DEVELOPMENT OF ENHANCER RNA-BASED BIOMARKERS IN FFPE TISSUE Complete
2018 R33 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Complete
1999 R43 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2007 R41 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2010 R21 RFA-CA-09-008 LEE, CHENG S UNIV OF MARYLAND, COLLEGE PARK CITP-BASED SELECTIVE TISSUE PROTEOME ENRICHMENT Complete
2014 R33 RFA-CA-13-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA MULTIPLEXED KINASE BIOSENSOR TECHNOLOGY TO DETECT LEUKEMIA SIGNALING WITH MASS SP Complete
2017 R33 RFA-CA-16-002 YATES, JOHN R SCRIPPS RESEARCH INSTITUTE Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry Complete
2001 R33 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2001 R33 PAR-98-067 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE Complete
2003 R41 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R21 RFA-CA-07-002 MINDERMAN, HANS ROSWELL PARK CANCER INSTITUTE CORP CLINICAL APPLICATION OF MULTISPECTRAL IMAGING FLOW CYTOMETRY Complete
2009 R43 RFA-CA-08-011 RUIZ, JOSEPH C TRANSPOSAGEN BIOPHARMACEUTICALS, INC. TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO Complete
2013 R33 RFA-CA-12-003 CUNNINGHAM, BRIAN T. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN PHOTONIC CRYSTAL ENHANCED FLUORESCENCE: DEVELOPMENT OF SENSORS STRUCTURES AND DET Complete
2016 R33 RFA-CA-15-003 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY Protein painting identifies therapeutic targets at protein-protein interfaces Complete
2000 R43 PAR-98-066 BAMDAD, CYNTHIA C. MINERVA BIOTECHNOLOGIES CORPORATION RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS Complete
2002 R43 PAR-01-105 LOGE, GARY SPECTRUMEDIX CORPORATION AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM Complete
2006 R21 RFA-CA-06-003 WANG, BINGHE GEORGIA STATE UNIVERSITY MRI CONTRAST AGENTS TARGETING CARBOHYDRATE BIOMARKERS Complete
2009 R21 RFA-CA-08-006 TANNER, SCOTT DAVID UNIVERSITY OF TORONTO DEVELOPMENT OF (PROTOTYPE) BEAD ARRAY FLOW CYTOMETER WITH MASS SPECTROMETER DETEC Complete
2012 R33 RFA-CA-12-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS DISCOVERY OF DEATH LIGANDS AGAINST CANCERS Complete
2016 R21 RFA-CA-15-002 LARMAN, HARRY BENJAMIN JOHNS HOPKINS UNIVERSITY A HIGHLY MULTIPLEXED GENE EXPRESSION PLATFORM FOR FIXED TISSUE SPECIMENS Complete
2019 R33 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Complete
2000 R21 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2002 R33 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete

Pages